Jun 2026 (Q2 FY26) — Aug 14, 2026
Milestone Scientific Q2 FY26 — CompuFlo Medical Business Drives Growth and Reimbursement Progress
Read the full callMilestone Scientific earnings: last reported Fri, 14 Aug 2026, for the quarter ended Jun 2026.
Reported
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 2.8 | +22.3% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | -37.4 | +26.5 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | -1.1 | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. The year-earlier figure was zero or a loss, so no percentage is shown. |
Price
1Y: $0.44 on 17 Oct 2025 → $0.33. High $0.55 (13 Aug 2026), low $0.25 (4 Feb 2026).
Overview
Call summaries
Milestone Scientific Q2 FY26 — CompuFlo Medical Business Drives Growth and Reimbursement Progress
Read the full callEvery analysed call
Financials
Net profit, year on year: +29% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 3 |
| Operating profit | -1 | -2 | -2 | -1 | -1 | -1 | -1 | -1 |
| Operating margin | −58.4% | −101.4% | −89.5% | −63.9% | −48.1% | −52.5% | −38.3% | −37.4% |
| Profit before tax | -1 | -2 | -2 | -1 | -1 | -1 | -1 | -1 |
| Tax rate | — | — | — | 0.0% | — | — | — | — |
| Net profit | -1 | -2 | -2 | -1 | -1 | -1 | -1 | -1 |
| EPS ($ per share) | -0.02 | — | -0.02 | -0.02 | -0.01 | — | -0.01 | -0.01 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reserves | -86 | -94 | -101 | -108 | -116 | -123 | -128 | -134 |
| Total liabilities | 5 | 5 | 3 | 4 | 4 | 3 | 4 | 5 |
| Fixed assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | — | 0 | 13 | 15 | 0 | 3 | 0 | — |
| Total assets | 6 | 7 | 20 | 20 | 14 | 11 | 10 | 8 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | -2 | -2 | -7 | -4 | -6 | -5 | -3 | -3 |
| Cash from investing | -0 | -0 | -0 | -0 | -0 | -3 | 3 | -0 |
| Cash from financing | -0 | 3 | 20 | 5 | -0 | 3 | 0 | 1 |
| Net cash flow | — | 1 | 13 | 1 | -6 | -6 | 0 | -2 |
| Capital expenditure | -0 | -0 | -0 | -0 | -0 | — | -0 | -0 |
| Free cash flow | -2 | -2 | -7 | -4 | -6 | — | -3 | -3 |
5 filings between Oct 20, 2025 and Oct 24, 2025.
Purchases
None
No insider bought shares.
Sales
$113.4K
5 sales by 1 insider
| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| BP4 S.r.l. | — | $113.4K | Oct 24, 2025 |
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Oct 24, 2025 | BP4 S.r.l. 10% owner | Sale | 100,000 | $44.0K |
| Oct 23, 2025 | BP4 S.r.l. 10% owner | Sale | 80,000 | $34.4K |
| Oct 22, 2025 | BP4 S.r.l. 10% owner | Sale | 14,427 | $6.5K |
| Oct 21, 2025 | BP4 S.r.l. 10% owner | Sale | 40,000 | $17.6K |
| Oct 20, 2025 | BP4 S.r.l. 10% owner | Sale | 24,034 | $10.9K |
| Oct 14, 2025 | BP4 S.r.l. 10% owner | Sale | 30,000 | $16.2K |
| Oct 13, 2025 | BP4 S.r.l. 10% owner | Sale | 10,000 | $5.5K |
| Oct 10, 2025 | BP4 S.r.l. 10% owner | Sale | 10,158 | $5.6K |
| Oct 8, 2025 | BP4 S.r.l. 10% owner | Sale | 30,000 | $13.9K |
| Oct 7, 2025 | BP4 S.r.l. 10% owner | Sale | 10,000 | $4.5K |
| Oct 3, 2025 | BP4 S.r.l. 10% owner | Sale | 10,000 | $4.5K |
| Oct 3, 2025 | BP4 S.r.l. 10% owner | Sale | 9,210 | $4.1K |
| Sep 11, 2025 | BP4 S.r.l. 10% owner | Sale | 10,000 | $5.9K |
| Jul 17, 2025 | BP4 S.r.l. 10% owner | Sale | 10,000 | $6.4K |
| Jul 8, 2025 | BP4 S.r.l. 10% owner | Sale | 11,489 | $7.9K |
| Jul 7, 2025 | BP4 S.r.l. 10% owner | Sale | 30,558 | $20.8K |
| Jul 3, 2025 | BP4 S.r.l. 10% owner | Sale | 50,853 | $34.1K |
| Jun 30, 2025 | BP4 S.r.l. 10% owner | Sale | 649 | $422 |
| Jun 27, 2025 | BP4 S.r.l. 10% owner | Sale | 10,000 | $7.3K |
| Jun 25, 2025 | BP4 S.r.l. 10% owner | Sale | 1,300 | $1.0K |
| Jun 24, 2025 | BP4 S.r.l. 10% owner | Sale | 10,000 | $8.1K |
| Jun 23, 2025 | BP4 S.r.l. 10% owner | Sale | 5,933 | $5.1K |
| Jun 18, 2025 | BP4 S.r.l. 10% owner | Sale | 1,693 | $1.5K |
| Jun 16, 2025 | BP4 S.r.l. 10% owner | Sale | 10,056 | $9.0K |
| Jun 11, 2025 | BP4 S.r.l. 10% owner | Sale | 23,797 | $21.5K |
| Jun 10, 2025 | BP4 S.r.l. 10% owner | Sale | 30,100 | $27.4K |
| Jun 9, 2025 | BP4 S.r.l. 10% owner | Sale | 20,266 | $18.3K |
| Jun 6, 2025 | BP4 S.r.l. 10% owner | Sale | 60,200 | $54.3K |
| Jun 5, 2025 | BP4 S.r.l. 10% owner | Sale | 26,855 | $24.4K |
| Jun 4, 2025 | BP4 S.r.l. 10% owner | Sale | 6,000 | $5.5K |
| Jun 3, 2025 | BP4 S.r.l. 10% owner | Sale | 8,000 | $7.5K |
| Jun 2, 2025 | BP4 S.r.l. 10% owner | Sale | 10,000 | $9.5K |
| May 30, 2025 | BP4 S.r.l. 10% owner | Sale | 12,118 | $11.3K |
| May 29, 2025 | BP4 S.r.l. 10% owner | Sale | 3,361 | $3.2K |
| May 28, 2025 | BP4 S.r.l. 10% owner | Sale | 14,256 | $13.7K |
| Dec 19, 2024 | McGeehan Michael Director | Sale | 20,000 | $15.5K |
| Oct 22, 2024 | OSSER LEONARD Director | Sale | 107,984 | $100.4K |
| Sep 24, 2024 | McGeehan Michael Director | Sale | 209 | $209 |
| Sep 20, 2024 | McGeehan Michael Director | Sale | 1,800 | $1.8K |
| Sep 19, 2024 | McGeehan Michael Director | Sale | 1,000 | $1.0K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Free account. Everything above stays public.
Write why you follow MILESTONE SCIENTIFIC INC. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading